 |
PDBsum entry 5tqf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
5tqf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Factor viia in complex with the inhibitor (11r)-11-[(1- aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13- diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3, 12-dione
|
|
Structure:
|
 |
Factor viia (heavy chain). Chain: h. Synonym: proconvertin,serum prothrombin conversion accelerator,spca, activated factor viia heavy chain. Engineered: yes. Factor viia (light chain). Chain: l. Synonym: proconvertin,serum prothrombin conversion accelerator,spca. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: f7. Expressed in: cricetinae. Expression_system_taxid: 10026. Expression_system_taxid: 10026
|
|
Resolution:
|
 |
|
1.85Å
|
R-factor:
|
0.184
|
R-free:
|
0.209
|
|
|
Authors:
|
 |
A.Wei
|
|
Key ref:
|
 |
J.M.Richter
et al.
(2017).
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.
Acs Med Chem Lett,
8,
67-72.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
24-Oct-16
|
Release date:
|
01-Feb-17
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains H, L:
E.C.3.4.21.21
- coagulation factor VIIa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolyzes one Arg-|-Ile bond in factor X to form factor Xa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Acs Med Chem Lett
8:67-72
(2017)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors.
|
|
J.M.Richter,
D.L.Cheney,
J.A.Bates,
A.Wei,
J.M.Luettgen,
A.R.Rendina,
T.M.Harper,
R.Narayanan,
P.C.Wong,
D.Seiffert,
R.R.Wexler,
E.S.Priestley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|